mouse ihc Search Results


94
Cell Signaling Technology Inc mouse immune cell phenotyping ihc antibody kit
Mouse Immune Cell Phenotyping Ihc Antibody Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse immune cell phenotyping ihc antibody kit/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
mouse immune cell phenotyping ihc antibody kit - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

93
Abcam mouse and rabbit specific hrp abc detection ihc kit
The antibodies and protocols used for immunohistochemical evaluation
Mouse And Rabbit Specific Hrp Abc Detection Ihc Kit, supplied by Abcam, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse and rabbit specific hrp abc detection ihc kit/product/Abcam
Average 93 stars, based on 1 article reviews
mouse and rabbit specific hrp abc detection ihc kit - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc primary macrophage membrane mark antibody kit
Figure 4. CETPi increases <t>macrophage</t> infiltration into site of infection and macrophage activation while maintaining tissue homeostasis at different stages of sepsis. (A and B) Representative staining figures of M1 macrophages by marker <t>CD86</t> in lung obtained 0 and 72 hours after infection by S. pneu- moniae from female APOA1.CETP mice treated with control or CETPi. Quantification was determined by random sampling spots on lungs of 3 different mice in each treatment and by measuring stained areas using ImageJ (H&E 0 hours, mean ± SD, 16.0 ± 2.6 [CETPi, n = 3] versus 2.7 ± 1.5 [Control, n = 3], unpaired t test, P = 0.002) (IHC 72 hours, mean ± SD, 6.0 ± 3.5 [CETPi, n = 3] versus 17.0 ± 7.9% [Control, n = 3], unpaired t test, P = 0.02). (C and D) Propor- tion of infiltrating inflammatory macrophages (CD11b+Ly6c+) and tissue repairing and inflammation resolving macrophages (CD11b+Ly6c–) in BAL samples obtained 24 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (CD11b+Ly6c+ 72 hours, mean ± SD, 5.6 ± 1.8 [CETPi, n = 4] versus 14.3 ± 6.1% [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.037) (CD11b+ Ly6c– 24 hours, mean ± SD, 62.1 ± 6.8 [CETPi, n = 4] ver- sus 45.6 ± 3.8 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.013; CD11b+ Ly6c– 72 hours, mean ± SD, 78.3 ± 9.1 [CETPi, n = 4] versus 34.7 ± 22.7 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.016). (E) Proportion of migrating monocytes (Ly6C++Ly6GDIM) in blood samples obtained 0 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (mean ± SD, 12.0 ± 2.7 [CETPi, n = 5] versus 0.14 ± 0.06 [Control, n = 4], unpaired t test, P = 0.00005). Data are shown as mean ± SD. *P < 0.05, **P < 0.01, ****P < 0.0001. ApoA1, apolipoprotein A-1; CETP, cholesteryl ester transfer protein; CD86, cluster of differentiation 86; CD11b, integrin α M; Ly6-C, lymphocyte antigen 6 locus C; Ly6-G, lymphocyte antigen 6 locus G.
Primary Macrophage Membrane Mark Antibody Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary macrophage membrane mark antibody kit/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
primary macrophage membrane mark antibody kit - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

90
Enzo Biochem saview ® (mouse/rabbit-hrp, dab) ihc kit
Figure 4. CETPi increases <t>macrophage</t> infiltration into site of infection and macrophage activation while maintaining tissue homeostasis at different stages of sepsis. (A and B) Representative staining figures of M1 macrophages by marker <t>CD86</t> in lung obtained 0 and 72 hours after infection by S. pneu- moniae from female APOA1.CETP mice treated with control or CETPi. Quantification was determined by random sampling spots on lungs of 3 different mice in each treatment and by measuring stained areas using ImageJ (H&E 0 hours, mean ± SD, 16.0 ± 2.6 [CETPi, n = 3] versus 2.7 ± 1.5 [Control, n = 3], unpaired t test, P = 0.002) (IHC 72 hours, mean ± SD, 6.0 ± 3.5 [CETPi, n = 3] versus 17.0 ± 7.9% [Control, n = 3], unpaired t test, P = 0.02). (C and D) Propor- tion of infiltrating inflammatory macrophages (CD11b+Ly6c+) and tissue repairing and inflammation resolving macrophages (CD11b+Ly6c–) in BAL samples obtained 24 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (CD11b+Ly6c+ 72 hours, mean ± SD, 5.6 ± 1.8 [CETPi, n = 4] versus 14.3 ± 6.1% [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.037) (CD11b+ Ly6c– 24 hours, mean ± SD, 62.1 ± 6.8 [CETPi, n = 4] ver- sus 45.6 ± 3.8 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.013; CD11b+ Ly6c– 72 hours, mean ± SD, 78.3 ± 9.1 [CETPi, n = 4] versus 34.7 ± 22.7 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.016). (E) Proportion of migrating monocytes (Ly6C++Ly6GDIM) in blood samples obtained 0 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (mean ± SD, 12.0 ± 2.7 [CETPi, n = 5] versus 0.14 ± 0.06 [Control, n = 4], unpaired t test, P = 0.00005). Data are shown as mean ± SD. *P < 0.05, **P < 0.01, ****P < 0.0001. ApoA1, apolipoprotein A-1; CETP, cholesteryl ester transfer protein; CD86, cluster of differentiation 86; CD11b, integrin α M; Ly6-C, lymphocyte antigen 6 locus C; Ly6-G, lymphocyte antigen 6 locus G.
Saview ® (Mouse/Rabbit Hrp, Dab) Ihc Kit, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/saview ® (mouse/rabbit-hrp, dab) ihc kit/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
saview ® (mouse/rabbit-hrp, dab) ihc kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
IHC World mouse anti-insulin antibody ihc world
Figure 4. CETPi increases <t>macrophage</t> infiltration into site of infection and macrophage activation while maintaining tissue homeostasis at different stages of sepsis. (A and B) Representative staining figures of M1 macrophages by marker <t>CD86</t> in lung obtained 0 and 72 hours after infection by S. pneu- moniae from female APOA1.CETP mice treated with control or CETPi. Quantification was determined by random sampling spots on lungs of 3 different mice in each treatment and by measuring stained areas using ImageJ (H&E 0 hours, mean ± SD, 16.0 ± 2.6 [CETPi, n = 3] versus 2.7 ± 1.5 [Control, n = 3], unpaired t test, P = 0.002) (IHC 72 hours, mean ± SD, 6.0 ± 3.5 [CETPi, n = 3] versus 17.0 ± 7.9% [Control, n = 3], unpaired t test, P = 0.02). (C and D) Propor- tion of infiltrating inflammatory macrophages (CD11b+Ly6c+) and tissue repairing and inflammation resolving macrophages (CD11b+Ly6c–) in BAL samples obtained 24 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (CD11b+Ly6c+ 72 hours, mean ± SD, 5.6 ± 1.8 [CETPi, n = 4] versus 14.3 ± 6.1% [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.037) (CD11b+ Ly6c– 24 hours, mean ± SD, 62.1 ± 6.8 [CETPi, n = 4] ver- sus 45.6 ± 3.8 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.013; CD11b+ Ly6c– 72 hours, mean ± SD, 78.3 ± 9.1 [CETPi, n = 4] versus 34.7 ± 22.7 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.016). (E) Proportion of migrating monocytes (Ly6C++Ly6GDIM) in blood samples obtained 0 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (mean ± SD, 12.0 ± 2.7 [CETPi, n = 5] versus 0.14 ± 0.06 [Control, n = 4], unpaired t test, P = 0.00005). Data are shown as mean ± SD. *P < 0.05, **P < 0.01, ****P < 0.0001. ApoA1, apolipoprotein A-1; CETP, cholesteryl ester transfer protein; CD86, cluster of differentiation 86; CD11b, integrin α M; Ly6-C, lymphocyte antigen 6 locus C; Ly6-G, lymphocyte antigen 6 locus G.
Mouse Anti Insulin Antibody Ihc World, supplied by IHC World, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-insulin antibody ihc world/product/IHC World
Average 90 stars, based on 1 article reviews
mouse anti-insulin antibody ihc world - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
GenomeMe Inc primary mouse monoclonal antibodies against survivin ihc 668
Figure 4. CETPi increases <t>macrophage</t> infiltration into site of infection and macrophage activation while maintaining tissue homeostasis at different stages of sepsis. (A and B) Representative staining figures of M1 macrophages by marker <t>CD86</t> in lung obtained 0 and 72 hours after infection by S. pneu- moniae from female APOA1.CETP mice treated with control or CETPi. Quantification was determined by random sampling spots on lungs of 3 different mice in each treatment and by measuring stained areas using ImageJ (H&E 0 hours, mean ± SD, 16.0 ± 2.6 [CETPi, n = 3] versus 2.7 ± 1.5 [Control, n = 3], unpaired t test, P = 0.002) (IHC 72 hours, mean ± SD, 6.0 ± 3.5 [CETPi, n = 3] versus 17.0 ± 7.9% [Control, n = 3], unpaired t test, P = 0.02). (C and D) Propor- tion of infiltrating inflammatory macrophages (CD11b+Ly6c+) and tissue repairing and inflammation resolving macrophages (CD11b+Ly6c–) in BAL samples obtained 24 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (CD11b+Ly6c+ 72 hours, mean ± SD, 5.6 ± 1.8 [CETPi, n = 4] versus 14.3 ± 6.1% [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.037) (CD11b+ Ly6c– 24 hours, mean ± SD, 62.1 ± 6.8 [CETPi, n = 4] ver- sus 45.6 ± 3.8 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.013; CD11b+ Ly6c– 72 hours, mean ± SD, 78.3 ± 9.1 [CETPi, n = 4] versus 34.7 ± 22.7 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.016). (E) Proportion of migrating monocytes (Ly6C++Ly6GDIM) in blood samples obtained 0 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (mean ± SD, 12.0 ± 2.7 [CETPi, n = 5] versus 0.14 ± 0.06 [Control, n = 4], unpaired t test, P = 0.00005). Data are shown as mean ± SD. *P < 0.05, **P < 0.01, ****P < 0.0001. ApoA1, apolipoprotein A-1; CETP, cholesteryl ester transfer protein; CD86, cluster of differentiation 86; CD11b, integrin α M; Ly6-C, lymphocyte antigen 6 locus C; Ly6-G, lymphocyte antigen 6 locus G.
Primary Mouse Monoclonal Antibodies Against Survivin Ihc 668, supplied by GenomeMe Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary mouse monoclonal antibodies against survivin ihc 668/product/GenomeMe Inc
Average 90 stars, based on 1 article reviews
primary mouse monoclonal antibodies against survivin ihc 668 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Maixin-Bio ltd ultrasensitive™ sp (mouse/rabbit) immunohistochemistry kit
Figure 4. CETPi increases <t>macrophage</t> infiltration into site of infection and macrophage activation while maintaining tissue homeostasis at different stages of sepsis. (A and B) Representative staining figures of M1 macrophages by marker <t>CD86</t> in lung obtained 0 and 72 hours after infection by S. pneu- moniae from female APOA1.CETP mice treated with control or CETPi. Quantification was determined by random sampling spots on lungs of 3 different mice in each treatment and by measuring stained areas using ImageJ (H&E 0 hours, mean ± SD, 16.0 ± 2.6 [CETPi, n = 3] versus 2.7 ± 1.5 [Control, n = 3], unpaired t test, P = 0.002) (IHC 72 hours, mean ± SD, 6.0 ± 3.5 [CETPi, n = 3] versus 17.0 ± 7.9% [Control, n = 3], unpaired t test, P = 0.02). (C and D) Propor- tion of infiltrating inflammatory macrophages (CD11b+Ly6c+) and tissue repairing and inflammation resolving macrophages (CD11b+Ly6c–) in BAL samples obtained 24 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (CD11b+Ly6c+ 72 hours, mean ± SD, 5.6 ± 1.8 [CETPi, n = 4] versus 14.3 ± 6.1% [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.037) (CD11b+ Ly6c– 24 hours, mean ± SD, 62.1 ± 6.8 [CETPi, n = 4] ver- sus 45.6 ± 3.8 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.013; CD11b+ Ly6c– 72 hours, mean ± SD, 78.3 ± 9.1 [CETPi, n = 4] versus 34.7 ± 22.7 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.016). (E) Proportion of migrating monocytes (Ly6C++Ly6GDIM) in blood samples obtained 0 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (mean ± SD, 12.0 ± 2.7 [CETPi, n = 5] versus 0.14 ± 0.06 [Control, n = 4], unpaired t test, P = 0.00005). Data are shown as mean ± SD. *P < 0.05, **P < 0.01, ****P < 0.0001. ApoA1, apolipoprotein A-1; CETP, cholesteryl ester transfer protein; CD86, cluster of differentiation 86; CD11b, integrin α M; Ly6-C, lymphocyte antigen 6 locus C; Ly6-G, lymphocyte antigen 6 locus G.
Ultrasensitive™ Sp (Mouse/Rabbit) Immunohistochemistry Kit, supplied by Maixin-Bio ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ultrasensitive™ sp (mouse/rabbit) immunohistochemistry kit/product/Maixin-Bio ltd
Average 90 stars, based on 1 article reviews
ultrasensitive™ sp (mouse/rabbit) immunohistochemistry kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
ERBA Diagnostics power vision homo-mouse ihc kit
Figure 4. CETPi increases <t>macrophage</t> infiltration into site of infection and macrophage activation while maintaining tissue homeostasis at different stages of sepsis. (A and B) Representative staining figures of M1 macrophages by marker <t>CD86</t> in lung obtained 0 and 72 hours after infection by S. pneu- moniae from female APOA1.CETP mice treated with control or CETPi. Quantification was determined by random sampling spots on lungs of 3 different mice in each treatment and by measuring stained areas using ImageJ (H&E 0 hours, mean ± SD, 16.0 ± 2.6 [CETPi, n = 3] versus 2.7 ± 1.5 [Control, n = 3], unpaired t test, P = 0.002) (IHC 72 hours, mean ± SD, 6.0 ± 3.5 [CETPi, n = 3] versus 17.0 ± 7.9% [Control, n = 3], unpaired t test, P = 0.02). (C and D) Propor- tion of infiltrating inflammatory macrophages (CD11b+Ly6c+) and tissue repairing and inflammation resolving macrophages (CD11b+Ly6c–) in BAL samples obtained 24 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (CD11b+Ly6c+ 72 hours, mean ± SD, 5.6 ± 1.8 [CETPi, n = 4] versus 14.3 ± 6.1% [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.037) (CD11b+ Ly6c– 24 hours, mean ± SD, 62.1 ± 6.8 [CETPi, n = 4] ver- sus 45.6 ± 3.8 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.013; CD11b+ Ly6c– 72 hours, mean ± SD, 78.3 ± 9.1 [CETPi, n = 4] versus 34.7 ± 22.7 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.016). (E) Proportion of migrating monocytes (Ly6C++Ly6GDIM) in blood samples obtained 0 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (mean ± SD, 12.0 ± 2.7 [CETPi, n = 5] versus 0.14 ± 0.06 [Control, n = 4], unpaired t test, P = 0.00005). Data are shown as mean ± SD. *P < 0.05, **P < 0.01, ****P < 0.0001. ApoA1, apolipoprotein A-1; CETP, cholesteryl ester transfer protein; CD86, cluster of differentiation 86; CD11b, integrin α M; Ly6-C, lymphocyte antigen 6 locus C; Ly6-G, lymphocyte antigen 6 locus G.
Power Vision Homo Mouse Ihc Kit, supplied by ERBA Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/power vision homo-mouse ihc kit/product/ERBA Diagnostics
Average 90 stars, based on 1 article reviews
power vision homo-mouse ihc kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Biogenex mouse-on-mouse iso-ihc kit
Figure 4. CETPi increases <t>macrophage</t> infiltration into site of infection and macrophage activation while maintaining tissue homeostasis at different stages of sepsis. (A and B) Representative staining figures of M1 macrophages by marker <t>CD86</t> in lung obtained 0 and 72 hours after infection by S. pneu- moniae from female APOA1.CETP mice treated with control or CETPi. Quantification was determined by random sampling spots on lungs of 3 different mice in each treatment and by measuring stained areas using ImageJ (H&E 0 hours, mean ± SD, 16.0 ± 2.6 [CETPi, n = 3] versus 2.7 ± 1.5 [Control, n = 3], unpaired t test, P = 0.002) (IHC 72 hours, mean ± SD, 6.0 ± 3.5 [CETPi, n = 3] versus 17.0 ± 7.9% [Control, n = 3], unpaired t test, P = 0.02). (C and D) Propor- tion of infiltrating inflammatory macrophages (CD11b+Ly6c+) and tissue repairing and inflammation resolving macrophages (CD11b+Ly6c–) in BAL samples obtained 24 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (CD11b+Ly6c+ 72 hours, mean ± SD, 5.6 ± 1.8 [CETPi, n = 4] versus 14.3 ± 6.1% [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.037) (CD11b+ Ly6c– 24 hours, mean ± SD, 62.1 ± 6.8 [CETPi, n = 4] ver- sus 45.6 ± 3.8 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.013; CD11b+ Ly6c– 72 hours, mean ± SD, 78.3 ± 9.1 [CETPi, n = 4] versus 34.7 ± 22.7 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.016). (E) Proportion of migrating monocytes (Ly6C++Ly6GDIM) in blood samples obtained 0 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (mean ± SD, 12.0 ± 2.7 [CETPi, n = 5] versus 0.14 ± 0.06 [Control, n = 4], unpaired t test, P = 0.00005). Data are shown as mean ± SD. *P < 0.05, **P < 0.01, ****P < 0.0001. ApoA1, apolipoprotein A-1; CETP, cholesteryl ester transfer protein; CD86, cluster of differentiation 86; CD11b, integrin α M; Ly6-C, lymphocyte antigen 6 locus C; Ly6-G, lymphocyte antigen 6 locus G.
Mouse On Mouse Iso Ihc Kit, supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse-on-mouse iso-ihc kit/product/Biogenex
Average 90 stars, based on 1 article reviews
mouse-on-mouse iso-ihc kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Bertin Corp prpc ihc (igg, mouse; a03202
Figure 4. CETPi increases <t>macrophage</t> infiltration into site of infection and macrophage activation while maintaining tissue homeostasis at different stages of sepsis. (A and B) Representative staining figures of M1 macrophages by marker <t>CD86</t> in lung obtained 0 and 72 hours after infection by S. pneu- moniae from female APOA1.CETP mice treated with control or CETPi. Quantification was determined by random sampling spots on lungs of 3 different mice in each treatment and by measuring stained areas using ImageJ (H&E 0 hours, mean ± SD, 16.0 ± 2.6 [CETPi, n = 3] versus 2.7 ± 1.5 [Control, n = 3], unpaired t test, P = 0.002) (IHC 72 hours, mean ± SD, 6.0 ± 3.5 [CETPi, n = 3] versus 17.0 ± 7.9% [Control, n = 3], unpaired t test, P = 0.02). (C and D) Propor- tion of infiltrating inflammatory macrophages (CD11b+Ly6c+) and tissue repairing and inflammation resolving macrophages (CD11b+Ly6c–) in BAL samples obtained 24 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (CD11b+Ly6c+ 72 hours, mean ± SD, 5.6 ± 1.8 [CETPi, n = 4] versus 14.3 ± 6.1% [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.037) (CD11b+ Ly6c– 24 hours, mean ± SD, 62.1 ± 6.8 [CETPi, n = 4] ver- sus 45.6 ± 3.8 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.013; CD11b+ Ly6c– 72 hours, mean ± SD, 78.3 ± 9.1 [CETPi, n = 4] versus 34.7 ± 22.7 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.016). (E) Proportion of migrating monocytes (Ly6C++Ly6GDIM) in blood samples obtained 0 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (mean ± SD, 12.0 ± 2.7 [CETPi, n = 5] versus 0.14 ± 0.06 [Control, n = 4], unpaired t test, P = 0.00005). Data are shown as mean ± SD. *P < 0.05, **P < 0.01, ****P < 0.0001. ApoA1, apolipoprotein A-1; CETP, cholesteryl ester transfer protein; CD86, cluster of differentiation 86; CD11b, integrin α M; Ly6-C, lymphocyte antigen 6 locus C; Ly6-G, lymphocyte antigen 6 locus G.
Prpc Ihc (Igg, Mouse; A03202, supplied by Bertin Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prpc ihc (igg, mouse; a03202/product/Bertin Corp
Average 90 stars, based on 1 article reviews
prpc ihc (igg, mouse; a03202 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
US Biological Life Sciences streptavidin hrp mouse bioassay ihc kit with dab chromagen
Figure 4. CETPi increases <t>macrophage</t> infiltration into site of infection and macrophage activation while maintaining tissue homeostasis at different stages of sepsis. (A and B) Representative staining figures of M1 macrophages by marker <t>CD86</t> in lung obtained 0 and 72 hours after infection by S. pneu- moniae from female APOA1.CETP mice treated with control or CETPi. Quantification was determined by random sampling spots on lungs of 3 different mice in each treatment and by measuring stained areas using ImageJ (H&E 0 hours, mean ± SD, 16.0 ± 2.6 [CETPi, n = 3] versus 2.7 ± 1.5 [Control, n = 3], unpaired t test, P = 0.002) (IHC 72 hours, mean ± SD, 6.0 ± 3.5 [CETPi, n = 3] versus 17.0 ± 7.9% [Control, n = 3], unpaired t test, P = 0.02). (C and D) Propor- tion of infiltrating inflammatory macrophages (CD11b+Ly6c+) and tissue repairing and inflammation resolving macrophages (CD11b+Ly6c–) in BAL samples obtained 24 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (CD11b+Ly6c+ 72 hours, mean ± SD, 5.6 ± 1.8 [CETPi, n = 4] versus 14.3 ± 6.1% [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.037) (CD11b+ Ly6c– 24 hours, mean ± SD, 62.1 ± 6.8 [CETPi, n = 4] ver- sus 45.6 ± 3.8 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.013; CD11b+ Ly6c– 72 hours, mean ± SD, 78.3 ± 9.1 [CETPi, n = 4] versus 34.7 ± 22.7 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.016). (E) Proportion of migrating monocytes (Ly6C++Ly6GDIM) in blood samples obtained 0 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (mean ± SD, 12.0 ± 2.7 [CETPi, n = 5] versus 0.14 ± 0.06 [Control, n = 4], unpaired t test, P = 0.00005). Data are shown as mean ± SD. *P < 0.05, **P < 0.01, ****P < 0.0001. ApoA1, apolipoprotein A-1; CETP, cholesteryl ester transfer protein; CD86, cluster of differentiation 86; CD11b, integrin α M; Ly6-C, lymphocyte antigen 6 locus C; Ly6-G, lymphocyte antigen 6 locus G.
Streptavidin Hrp Mouse Bioassay Ihc Kit With Dab Chromagen, supplied by US Biological Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/streptavidin hrp mouse bioassay ihc kit with dab chromagen/product/US Biological Life Sciences
Average 90 stars, based on 1 article reviews
streptavidin hrp mouse bioassay ihc kit with dab chromagen - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
HistoTox Labs ihc staining of mouse nf-kb p65
Figure 4. CETPi increases <t>macrophage</t> infiltration into site of infection and macrophage activation while maintaining tissue homeostasis at different stages of sepsis. (A and B) Representative staining figures of M1 macrophages by marker <t>CD86</t> in lung obtained 0 and 72 hours after infection by S. pneu- moniae from female APOA1.CETP mice treated with control or CETPi. Quantification was determined by random sampling spots on lungs of 3 different mice in each treatment and by measuring stained areas using ImageJ (H&E 0 hours, mean ± SD, 16.0 ± 2.6 [CETPi, n = 3] versus 2.7 ± 1.5 [Control, n = 3], unpaired t test, P = 0.002) (IHC 72 hours, mean ± SD, 6.0 ± 3.5 [CETPi, n = 3] versus 17.0 ± 7.9% [Control, n = 3], unpaired t test, P = 0.02). (C and D) Propor- tion of infiltrating inflammatory macrophages (CD11b+Ly6c+) and tissue repairing and inflammation resolving macrophages (CD11b+Ly6c–) in BAL samples obtained 24 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (CD11b+Ly6c+ 72 hours, mean ± SD, 5.6 ± 1.8 [CETPi, n = 4] versus 14.3 ± 6.1% [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.037) (CD11b+ Ly6c– 24 hours, mean ± SD, 62.1 ± 6.8 [CETPi, n = 4] ver- sus 45.6 ± 3.8 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.013; CD11b+ Ly6c– 72 hours, mean ± SD, 78.3 ± 9.1 [CETPi, n = 4] versus 34.7 ± 22.7 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.016). (E) Proportion of migrating monocytes (Ly6C++Ly6GDIM) in blood samples obtained 0 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (mean ± SD, 12.0 ± 2.7 [CETPi, n = 5] versus 0.14 ± 0.06 [Control, n = 4], unpaired t test, P = 0.00005). Data are shown as mean ± SD. *P < 0.05, **P < 0.01, ****P < 0.0001. ApoA1, apolipoprotein A-1; CETP, cholesteryl ester transfer protein; CD86, cluster of differentiation 86; CD11b, integrin α M; Ly6-C, lymphocyte antigen 6 locus C; Ly6-G, lymphocyte antigen 6 locus G.
Ihc Staining Of Mouse Nf Kb P65, supplied by HistoTox Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ihc staining of mouse nf-kb p65/product/HistoTox Labs
Average 90 stars, based on 1 article reviews
ihc staining of mouse nf-kb p65 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


The antibodies and protocols used for immunohistochemical evaluation

Journal: Veterinary Medicine and Science

Article Title: A case of generalised cutaneous apocrine cystomatosis in a Pekingese dog

doi: 10.1002/vms3.711

Figure Lengend Snippet: The antibodies and protocols used for immunohistochemical evaluation

Article Snippet: Mouse and rabbit‐specific HRP (ABC) detection IHC kit , Manufacturer instructions , , Abcam; Cambridge, UK.

Techniques: Immunohistochemical staining, Incubation

Figure 4. CETPi increases macrophage infiltration into site of infection and macrophage activation while maintaining tissue homeostasis at different stages of sepsis. (A and B) Representative staining figures of M1 macrophages by marker CD86 in lung obtained 0 and 72 hours after infection by S. pneu- moniae from female APOA1.CETP mice treated with control or CETPi. Quantification was determined by random sampling spots on lungs of 3 different mice in each treatment and by measuring stained areas using ImageJ (H&E 0 hours, mean ± SD, 16.0 ± 2.6 [CETPi, n = 3] versus 2.7 ± 1.5 [Control, n = 3], unpaired t test, P = 0.002) (IHC 72 hours, mean ± SD, 6.0 ± 3.5 [CETPi, n = 3] versus 17.0 ± 7.9% [Control, n = 3], unpaired t test, P = 0.02). (C and D) Propor- tion of infiltrating inflammatory macrophages (CD11b+Ly6c+) and tissue repairing and inflammation resolving macrophages (CD11b+Ly6c–) in BAL samples obtained 24 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (CD11b+Ly6c+ 72 hours, mean ± SD, 5.6 ± 1.8 [CETPi, n = 4] versus 14.3 ± 6.1% [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.037) (CD11b+ Ly6c– 24 hours, mean ± SD, 62.1 ± 6.8 [CETPi, n = 4] ver- sus 45.6 ± 3.8 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.013; CD11b+ Ly6c– 72 hours, mean ± SD, 78.3 ± 9.1 [CETPi, n = 4] versus 34.7 ± 22.7 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.016). (E) Proportion of migrating monocytes (Ly6C++Ly6GDIM) in blood samples obtained 0 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (mean ± SD, 12.0 ± 2.7 [CETPi, n = 5] versus 0.14 ± 0.06 [Control, n = 4], unpaired t test, P = 0.00005). Data are shown as mean ± SD. *P < 0.05, **P < 0.01, ****P < 0.0001. ApoA1, apolipoprotein A-1; CETP, cholesteryl ester transfer protein; CD86, cluster of differentiation 86; CD11b, integrin α M; Ly6-C, lymphocyte antigen 6 locus C; Ly6-G, lymphocyte antigen 6 locus G.

Journal: JCI insight

Article Title: CETP inhibition enhances monocyte activation and bacterial clearance and reduces streptococcus pneumonia-associated mortality in mice.

doi: 10.1172/jci.insight.173205

Figure Lengend Snippet: Figure 4. CETPi increases macrophage infiltration into site of infection and macrophage activation while maintaining tissue homeostasis at different stages of sepsis. (A and B) Representative staining figures of M1 macrophages by marker CD86 in lung obtained 0 and 72 hours after infection by S. pneu- moniae from female APOA1.CETP mice treated with control or CETPi. Quantification was determined by random sampling spots on lungs of 3 different mice in each treatment and by measuring stained areas using ImageJ (H&E 0 hours, mean ± SD, 16.0 ± 2.6 [CETPi, n = 3] versus 2.7 ± 1.5 [Control, n = 3], unpaired t test, P = 0.002) (IHC 72 hours, mean ± SD, 6.0 ± 3.5 [CETPi, n = 3] versus 17.0 ± 7.9% [Control, n = 3], unpaired t test, P = 0.02). (C and D) Propor- tion of infiltrating inflammatory macrophages (CD11b+Ly6c+) and tissue repairing and inflammation resolving macrophages (CD11b+Ly6c–) in BAL samples obtained 24 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (CD11b+Ly6c+ 72 hours, mean ± SD, 5.6 ± 1.8 [CETPi, n = 4] versus 14.3 ± 6.1% [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.037) (CD11b+ Ly6c– 24 hours, mean ± SD, 62.1 ± 6.8 [CETPi, n = 4] ver- sus 45.6 ± 3.8 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.013; CD11b+ Ly6c– 72 hours, mean ± SD, 78.3 ± 9.1 [CETPi, n = 4] versus 34.7 ± 22.7 [Control, n = 3], unpaired t test with Bonferroni correction, P = 0.016). (E) Proportion of migrating monocytes (Ly6C++Ly6GDIM) in blood samples obtained 0 and 72 hours after infection from female APOA1.CETP mice treated with control or CETPi (mean ± SD, 12.0 ± 2.7 [CETPi, n = 5] versus 0.14 ± 0.06 [Control, n = 4], unpaired t test, P = 0.00005). Data are shown as mean ± SD. *P < 0.05, **P < 0.01, ****P < 0.0001. ApoA1, apolipoprotein A-1; CETP, cholesteryl ester transfer protein; CD86, cluster of differentiation 86; CD11b, integrin α M; Ly6-C, lymphocyte antigen 6 locus C; Ly6-G, lymphocyte antigen 6 locus G.

Article Snippet: For IHC, tissue cross-sections were incubated with a primary macrophage membrane mark antibody kit (CD86 and CD206, 97624, CST) to identify specific cell types of macrophages followed by secondary antibodies using the alkaline phosphatase system to amplify signals.

Techniques: Infection, Activation Assay, Staining, Marker, Control, Sampling

Figure 5. CETPi decreases caspase-1 and COX-2 protein expression in human and mouse cells. (A–C) COX-2 and Caspase-1 expression in PBMCs treated with increasing doses of CETPi. (D–E) COX-2 expression in THP1 cells treated with control or CETPi (1 μM) (mean ± SD, 1.00 ± 0.42 [Control, n = 3] versus 1.31 ± 0.38 [CETPi, n = 3], unpaired t test, P = 0.03). (F–G) Caspase-1 in THP1 cells treated with control or CETPi (1 μM) (mean ± SD, 1.00 ± 0.19 [Control, n = 3] versus 2.02 ± 0.11 [CETPi, n = 3], unpaired t test, P = 0.02). (H) Expression of ROS in THP1 cells treated with control or CETPi (2 μM), (mean ± SD, 2.45 ± 0.36 [CETPi, n = 6] versus 1.00 ± 0.19 [Control, n = 6], unpaired t test, P = 0.00005). (I–K) Expression of COX-2 and CETP in RAW264.7 cells after adenovirus transfection induced-CETP overexpression in increasing MOIs. (L–M) Expression of pro–caspase-1 and cleaved caspase-1 in RAW 264.7 cells after adeno- virus transfection–induced CETP overexpression at MOI = 1.6. Pro–caspase-1: mean ± SD, 1.00 ± 0.15 (Control, n = 3) versus 0.45 ± 0.22 (CETP overexpress, n = 3), unpaired t test, P = 0.02; cleaved caspase-1: mean ± SD, 1.00 ± 0.14 (Control, n = 3) versus 0.58 ± 0.16 (CETP overexpress, n = 3), unpaired t test, P = 0.03. Data displayed as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001. Caspase-1, caspase-1/IL-1 converting enzyme; COX-2, prostaglandin-endoperoxide synthase 2; MOI, multiplicity of infection; PBMC, human peripheral blood mononuclear cell; RAW, murine macrophage cell; ROS, reactive oxygen species; THP1, human peripheral blood monocyte.

Journal: JCI insight

Article Title: CETP inhibition enhances monocyte activation and bacterial clearance and reduces streptococcus pneumonia-associated mortality in mice.

doi: 10.1172/jci.insight.173205

Figure Lengend Snippet: Figure 5. CETPi decreases caspase-1 and COX-2 protein expression in human and mouse cells. (A–C) COX-2 and Caspase-1 expression in PBMCs treated with increasing doses of CETPi. (D–E) COX-2 expression in THP1 cells treated with control or CETPi (1 μM) (mean ± SD, 1.00 ± 0.42 [Control, n = 3] versus 1.31 ± 0.38 [CETPi, n = 3], unpaired t test, P = 0.03). (F–G) Caspase-1 in THP1 cells treated with control or CETPi (1 μM) (mean ± SD, 1.00 ± 0.19 [Control, n = 3] versus 2.02 ± 0.11 [CETPi, n = 3], unpaired t test, P = 0.02). (H) Expression of ROS in THP1 cells treated with control or CETPi (2 μM), (mean ± SD, 2.45 ± 0.36 [CETPi, n = 6] versus 1.00 ± 0.19 [Control, n = 6], unpaired t test, P = 0.00005). (I–K) Expression of COX-2 and CETP in RAW264.7 cells after adenovirus transfection induced-CETP overexpression in increasing MOIs. (L–M) Expression of pro–caspase-1 and cleaved caspase-1 in RAW 264.7 cells after adeno- virus transfection–induced CETP overexpression at MOI = 1.6. Pro–caspase-1: mean ± SD, 1.00 ± 0.15 (Control, n = 3) versus 0.45 ± 0.22 (CETP overexpress, n = 3), unpaired t test, P = 0.02; cleaved caspase-1: mean ± SD, 1.00 ± 0.14 (Control, n = 3) versus 0.58 ± 0.16 (CETP overexpress, n = 3), unpaired t test, P = 0.03. Data displayed as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001. Caspase-1, caspase-1/IL-1 converting enzyme; COX-2, prostaglandin-endoperoxide synthase 2; MOI, multiplicity of infection; PBMC, human peripheral blood mononuclear cell; RAW, murine macrophage cell; ROS, reactive oxygen species; THP1, human peripheral blood monocyte.

Article Snippet: For IHC, tissue cross-sections were incubated with a primary macrophage membrane mark antibody kit (CD86 and CD206, 97624, CST) to identify specific cell types of macrophages followed by secondary antibodies using the alkaline phosphatase system to amplify signals.

Techniques: Expressing, Control, Transfection, Over Expression, Virus, Infection